Back to Search
SANDRA MASTRANGELO, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1801473426IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryPSYCHIATRY
Education
GEISEL SCHOOL OF MEDICINE AT DARTMOUTH
Class of 2021
Research & Publications (13)
Quercetin reduces chromosome aberrations induced by atrazine in the Allium cepa test.
PMID 16416428·Environ Mol Mutagen·2006
8-other
Antimutagenic activity of a secoisopimarane diterpenoid from Salvia cinnabarina M. Martens et Galeotti in the bacterial reverse mutation assay.
PMID 19497346·Food Chem Toxicol·2009
7-preclinical
Severe hyperleukocytosis and multifocal intracranial haemorrhage: not always a fatal outcome.
PMID 19466507·Int J Hematol·2009
5-case
Hepatotoxicity from green tea: a review of the literature and two unpublished cases.
PMID 19198822·Eur J Clin Pharmacol·2009
5-case
Effects of Cimicifuga racemosa extract on liver morphology and hepatic function indices.
PMID 18434119·Phytomedicine·2008
7-preclinical
Successful treatment with oral valganciclovir in immunocompetent infant with gastrointestinal manifestations of cytomegalovirus infection.
PMID 17006527·J Perinatol·2006
5-case
The antimutagenic activity of Lavandula angustifolia (lavender) essential oil in the bacterial reverse mutation assay.
PMID 15907354·Food Chem Toxicol·2005
7-preclinical
Clastogenicity of atrazine assessed with the Allium cepa test.
PMID 14991755·Environ Mol Mutagen·2004
8-other
A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma.
PMID 14635085·Cancer·2003
3-trial
Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients.
PMID 13680160·Cancer Chemother Pharmacol·2003
3-trial
In vitro assessment of mutagenicity and clastogenicity of BDE-99, a pentabrominated diphenyl ether flame retardant.
PMID 12929120·Environ Mol Mutagen·2003
8-other
Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
PMID 11207038·Br J Cancer·2001
3-trial
Radioresistant sensitization of neuroblastoma by cisplatin?
PMID 10881013·Med Pediatr Oncol·2000
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 60 FENWOOD RD
BOSTON, MA 02115 - Phone
- (617) 732-5500
Quick Facts
- NPI
- 1801473426
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 5
- Publications
- 13
Are you this provider?
Claim Your Profile